The FDA granted Fast Track designation for treatments, and the company Oncolytics Biotech began using LinkedIn for its social media presence.
1 report, 1 independent
Updated Aug 28
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The FDA granted Fast Track designation for treatments, and the company Oncolytics Biotech began using LinkedIn for its social media presence.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Oncolytics Biotech
Nothing else this week.
-
LinkedIn
American social networking website for people in professional occupations
Related events
- Syndax Pharmaceuticals has FDA-approved therapies in its pipeline and uses LinkedIn for company communication.
- Kura Oncology announced the commercialization of an FDA-approved drug and began using LinkedIn for company information.
- A company with FDA-approved therapies used LinkedIn for information and its board approved a stock award for CFO hiring.
- Pelthos Therapeutics Inc. followed another company on LinkedIn on November 1, 2026.
- Pelthos Therapeutics Inc. began using LinkedIn for investor outreach on July 1, 2026.
Coverage
Newest first; wire copies grouped- CNW GroupOncolytics Biotech® Announces Upcoming Investor Conferences in September SAN DIEGO, Aug. 28, 2025 /CNW/ -- Oncolytics Biotech® Inc. (Nasdaq: ONCY) ("Oncolytics" or the "Company"), a clinical-stage im